Peer-influenced content. Sources you trust. No registration required. This is HCN.
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
Psychiatry Advisor
Discover how testosterone therapy is drastically improving mental health outcomes for transgender and gender-diverse individuals.
Psychiatry October 10th 2023
MDLinx
The Hein case has ignited a national debate on the ethics of gender-affirming care for minors, raising questions about informed consent and the role of healthcare providers in these complex decisions.
All Specialties October 4th 2023
Conexiant
This groundbreaking study provides new insights into the risk of prostate cancer in transgender women, emphasizing the need for tailored screening and awareness among healthcare providers.
Oncology, Medical September 11th 2023
Pharmacy Today
The recent ban on gender-affirming care for minors in Texas underscores the urgent need for pharmacists to act as knowledgeable allies and advocates for transgender patients. Your role in education, advocacy, and trust-building is now more crucial than ever; learn more about how you can help.
Clinical Pharmacology July 31st 2023
Journal of the American Pharmacists Association (JAPhA)
Explore how neighborhood pharmacists are tackling the Gender-Affirming Care Guide’s difficulty of comprehension and application. The study provides a critical analysis of community pharmacists’ awareness and use of the Gender-Affirming Care Guide. Unveiled by the American Pharmacists Association and Human Rights Campaign in March 2021, the guide represents a pivotal tool for delivering competent and respectful care to transgender and gender-diverse patients. Nonetheless, reports on pharmacists’ familiarity with, and adherence to, the guide are currently lacking. To examine this, an anonymous survey, structured around the guide’s principles, was sent to 700 Ohio community pharmacists. Of the 688 recipients, a mere 12% responded, revealing a stark lack of awareness about the guide – only 10% knew of its existence. Moreover, their self-reported ability to define key terminologies varied widely. Indeed, 95% could correctly define “transgender,” but only 14% knew “intersectionality.” The report underscores the importance of adopting the guide’s suggested practices. Notably, it found that 61% collected patients’ preferred names, and 54% considered transgender, gender-diverse, or non-heterosexual patients during staff training. Nevertheless, less than half claimed their pharmacy software managed critical gender-related data effectively. Despite these shortcomings, the surveyed pharmacists displayed a substantial interest in learning more about the guide’s contents. […]
Clinical Pharmacology May 31st 2023